★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★

Checking

Stock Profile

Dassault Systemes SE (DSY) Moat Analysis

Dassault Systemes SE

DSY · Euronext Paris

Market cap (USD)$29.2B
SectorTechnology
IndustrySoftware - Application
CountryFR
Data as of
Moat score
85/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Request update

Spot something outdated? Send a quick note and source so we can refresh this profile.

Overview

Dassault Systemes is an industrial and life-sciences software company spanning enterprise PLM/CAD/CAE, SOLIDWORKS and Centric, and Medidata/BIOVIA. Q1 2026 software revenue was EUR1.375B: 54.5% Industrial Innovation, 26.7% Mainstream Innovation and 18.8% Life Sciences. The primary advantage is data and workflow lock-in across long-lived design, engineering, manufacturing and clinical processes, reinforced by suite breadth and an 85% recurring software mix. A June 2026 GBP30M UK fusion contract illustrates 3DEXPERIENCE becoming core plant-information infrastructure for a program targeting 2040. Historical milestones, sales-channel scale, generic compliance certifications and vendor rankings are not treated as standalone moats. Q2 results are due July 23.

Primary segment

Industrial Innovation

Market structure

Oligopoly

Market share

HHI:

Coverage

3 segments · 6 tags

Updated 2026-07-12

Segments

Industrial Innovation

Enterprise PLM, CAD/CAE, and digital manufacturing software for discrete industries

Revenue

54.5%

Structure

Oligopoly

Pricing

strong

Share

Peers

SIE.DEPTCADSKANSS+1

Mainstream Innovation

Mid-market mechanical CAD and product design/PLM software (e.g., SOLIDWORKS and Centric PLM)

Revenue

26.7%

Structure

Oligopoly

Pricing

moderate

Share

Peers

ADSKPTCSIE.DE

Life Sciences

Life sciences software for clinical trials, data, and regulated R&D workflows (e.g., Medidata and related platforms)

Revenue

18.8%

Structure

Oligopoly

Pricing

moderate

Share

Peers

VEEVORCLIQV

Moat Claims

Industrial Innovation

Enterprise PLM, CAD/CAE, and digital manufacturing software for discrete industries

Revenue share uses Q1 2026 non-IFRS software revenue: Industrial Innovation EUR749.6M of EUR1,375.3M. Services revenue is not allocated by product line.

Oligopoly

Data Workflow Lockin

Demand

Strength

Strength 5 of 5

Durability

Durability 3 of 3

Confidence

Confidence 4 of 5

Evidence

Evidence 4 of 5

3DEXPERIENCE platform-based workflows (design -> engineering -> manufacturing) embed deeply in enterprise processes; migrations require data conversion, integration rewiring, and retraining across large teams and suppliers.

Data Workflow Lockin moat: definition, examples, and stocks

Erosion risks

  • Customer push for multi-CAD interoperability and open standards
  • Cloud-native competitors reducing deployment friction
  • Cyclical industrial capex (auto/aerospace) impacting spend

Leading indicators

  • 3DEXPERIENCE subscription growth
  • Recurring revenue share of software revenue
  • Large multi-year platform standardization deals

Counterarguments

  • Siemens Digital Industries Software and PTC offer comparable end-to-end platforms
  • Many enterprises run heterogeneous toolchains; standardization is not universal

Suite Bundling

Demand

Strength

Strength 4 of 5

Durability

Durability 3 of 3

Confidence

Confidence 4 of 5

Evidence

Evidence 2 of 5

Portfolio breadth (e.g., CAD + PLM/data + manufacturing + simulation) enables cross-sell and makes displacement harder than single-point tools.

Suite Bundling moat: definition, examples, and stocks

Erosion risks

  • Customers selectively unbundle into specialist tools
  • Bundling discounts compress realized pricing

Leading indicators

  • Multi-product attach rates (roles/apps per customer)
  • Cross-sell/upsell contribution to growth

Counterarguments

  • Best-of-breed tools can outperform integrated suites in specific functions
  • Interoperability layers can reduce bundling advantage

Mainstream Innovation

Mid-market mechanical CAD and product design/PLM software (e.g., SOLIDWORKS and Centric PLM)

Revenue share uses Q1 2026 non-IFRS software revenue: Mainstream Innovation EUR366.9M of EUR1,375.3M.

Oligopoly

Switching Costs General

Demand

Strength

Strength 4 of 5

Durability

Durability 2 of 3

Confidence

Confidence 3 of 5

Evidence

Evidence 3 of 5

Engineer training, accumulated CAD models, and downstream integrations raise switching costs, supporting a high recurring-revenue mix, but SMB segments can switch faster than large enterprises.

Switching Costs General moat: definition, examples, and stocks

Erosion risks

  • Cloud-native CAD tools lowering onboarding and switching friction
  • Price competition and discounting in SMB
  • Greater use of neutral interchange formats reducing lock-in

Leading indicators

  • Recurring revenue share
  • Subscription seat growth in SOLIDWORKS-related offers
  • Churn / renewal-rate disclosures (if provided)

Counterarguments

  • Autodesk and others can win new teams with integrated cloud tooling
  • Many organizations already operate in multi-CAD environments

Life Sciences

Life sciences software for clinical trials, data, and regulated R&D workflows (e.g., Medidata and related platforms)

Revenue share uses Q1 2026 non-IFRS software revenue: Life Sciences EUR258.8M of EUR1,375.3M.

Oligopoly

Data Workflow Lockin

Demand

Strength

Strength 4 of 5

Durability

Durability 3 of 3

Confidence

Confidence 4 of 5

Evidence

Evidence 3 of 5

Unified clinical platforms connect patient/site workflows and study data; integrations and accumulated operational data increase the cost and risk of switching during multi-year trials.

Data Workflow Lockin moat: definition, examples, and stocks

Erosion risks

  • Trial-start slowdowns reducing usage and expansion
  • Customers adopting multi-vendor clinical stacks
  • Data portability demands and integration standards reducing lock-in

Leading indicators

  • Life Sciences subscription growth and renewals
  • Number/scale of expanded pharma/CRO partnerships
  • Clinical-trial activity indicators (e.g., study starts)

Counterarguments

  • Large pharma can standardize on alternative platforms and integrate across vendors
  • Competitive offerings can replicate workflow capabilities over time

Evidence

other

Volkswagen Group has chosen the 3DEXPERIENCE platform on the cloud as a main engineering and manufacturing platform.

Large OEM standardization indicates high workflow/data lock-in and high switching costs.

other

Companies can digitally connect upstream thinking to design, engineering, manufacturing, sales, marketing, and ownership.

Supports the end-to-end workflow integration claim central to lock-in.

other

...highlighting our unique and indispensable position with our clients...

Management framing supports indispensability/switching-cost narrative (interpretation, not proof).

news

a core component of STEP’s Plant Information Management System

The GBP30M expansion embeds 3DEXPERIENCE as the digital engineering foundation for a sovereign fusion program with a 2040 target.

other

Industrial Innovation... led by CATIA, DELMIA and ENOVIA.

Shows multi-application suite within the segment; also ties to the segment definition.

Showing 5 of 12 sources.

Risks & Indicators

Erosion risks

  • Customer push for multi-CAD interoperability and open standards
  • Cloud-native competitors reducing deployment friction
  • Cyclical industrial capex (auto/aerospace) impacting spend
  • Complexity or platform fatigue driving best-of-breed point-solution adoption
  • Customers selectively unbundle into specialist tools
  • Bundling discounts compress realized pricing

Leading indicators

  • 3DEXPERIENCE subscription growth
  • Recurring revenue share of software revenue
  • Large multi-year platform standardization deals
  • Multi-product attach rates (roles/apps per customer)
  • Cross-sell/upsell contribution to growth
  • Recurring revenue share

Keep the research going

Created 2025-12-29
Updated 2026-07-12

More Rankings & Systems

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.